By Najiyya Budaly ( May 7, 2026, 2:00 PM BST) -- Angelini Pharma SpA will buy U.S. rival Catalyst Pharmaceuticals Inc. for $4.1 billion in cash, the companies said Thursday, a transaction that will give the Italian company access to therapeutics for rare diseases affecting the brain....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.